- Home
- About
- Find staff
- Björg Kristjansdottir
Björg Kristjansdottir
Benämning saknas
Department of Obstetrics and Gynecology-
Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian
cancer
S. Jain, N. Nadeem, B. Ulfenborg, M. Makela, S. A. Ruma, J. Terava, K. Huhtinen, J. Leivo, Björg Kristjansdottir, K. Pettersson, Karin Sundfeldt, K. Gidwani
International Journal of Cancer - 2022 -
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control
study
Anna Darelius, Björg Kristjansdottir, Pernilla Dahm-Kähler, Annika Strandell
International Journal of Cancer - 2021 -
Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation
assay.
Constantina Mateoiu, Varvara Vitiazeva, Björg Kristjansdottir, Birgitta Weijdegård, Jessica Örnros, Radiosa Gallini, Masood Kamali-Moghaddam, Karin Sundfeldt, Niclas G. Karlsson
Glycobiology - 2021 -
Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian
Cancer
L. Liljedahl, J. Malmstrom, Björg Kristjansdottir, S. Waldemarson, Karin Sundfeldt
Cancers - 2021 -
Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor
diagnostics
Maria Lycke, Benjamin Ulfenborg, Jacob Malchau Lauesgaard, Björg Kristjansdottir, Karin Sundfeldt
Clinical Chemistry and Laboratory Medicine - 2021 -
Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and
Biomarkers
Maria Lycke, B. Ulfenborg, Björg Kristjansdottir, Karin Sundfeldt
Journal of Clinical Medicine - 2020 -
Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type
2.
Simonas Marcišauskas, Benjamin Ulfenborg, Björg Kristjansdottir, Sofia Waldemarson, Karin Sundfeldt
Journal of proteomics - 2019 -
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal
metastases
N. S. Meagher, L. Wang, P. F. Rambau, M. P. Intermaggio, D. G. Huntsman, L. R. Wilkens, M. A. El-Bahrawy, R. B. Ness, K. Odunsi, H. Steed, E. Herpel, M. S. Anglesio, B. Zhang, N. Lambie, A. J. Swerdlow, J. Lubiński, R. A. Vierkant, E. L. Goode, U. Menon, A. Toloczko-Grabarek, O. Oszurek, S. Bilic, A. Talhouk, M. García-Closas, Q. Wang, A. Tan, R. Farrell, C. J. Kennedy, M. Jimenez-Linan, Karin Sundfeldt, J. L. Etter, J. Menkiszak, M. T. Goodman, P. Klonowski, Y. Leung, S. J. Winham, K. B. Moysich, S. Behrens, T. Kluz, R. P. Edwards, J. Gronwald, F. Modugno, B. Y. Hernandez, C. Chow, L. E. Kelemen, G. L. Keeney, M. E. Carney, Y. Natanzon, G. Robertson, R. Sharma, S. A. Gayther, J. Alsop, H. Luk, C. Karpinskyj, I. Campbell, P. Sinn, A. Gentry-Maharaj, P. Coulson, J. Chang-Claude, M. Shah, M. Widschwendter, K. Tang, M. J. Schoemaker, J. M. Koziak, L. S. Cook, J. D. Brenton, F. Daley, Björg Kristjansdottir, Constantina Mateoiu, M. C. Larson, P. R. Harnett, A. Jung, A. deFazio, K. L. Gorringe, P. D. P. Pharoah, P. Minoo, C. Stewart, O. F. Bathe, X. Gui, P. Cohen, S. J. Ramus, M. Köbel
Modern Pathology - 2019 -
A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy
index
Maria Lycke, Björg Kristjansdottir, Karin Sundfeldt
Gynecologic Oncology - 2018 -
Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic
review.
A Darelius, Maria Lycke, Jenny Kindblom, Björg Kristjansdottir, Karin Sundfeldt, Annika Strandell
BJOG : an international journal of obstetrics and gynaecology - 2017 -
Diagnostic potential of tumor DNA from ovarian cyst
fluid
Y. X. Wang, Karin Sundfeldt, Constantina Mateoiu, I. M. Shih, R. J. Kurman, J. Schaefer, N. Silliman, I. Kinde, S. Springer, M. Foote, Björg Kristjansdottir, N. James, K. W. Kinzler, N. Papadopoulos, L. A. Diaz, B. Vogelstein
Elife - 2016 -
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian
mass.
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A R Lok, Anna Stiekema, Irene Mutz-Dehbalaie, Adam N Rosenthal, Elizabeth K Moore, Beth A Schodin, Walfrido W Sumpaico, Karin Sundfeldt, Björg Kristjansdottir, Ignacio Zapardiel, Claus K Høgdall
Gynecologic oncology - 2015 -
Early inflammatory response in epithelial ovarian tumor cyst
fluids.
Björg Kristjansdottir, Karolina Partheen, Eric T Fung, Christine Yip, Kristina Levan, Karin Sundfeldt
Cancer medicine - 2014 -
Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian
cancer.
Björg Kristjansdottir, Kristina Levan, Karolina Partheen, Karin Sundfeldt
Gynecologic oncology - 2013 -
Early Diagnosis of Epithelial Ovarian Cancer - Analysis of Novel
Biomarkers
-
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis,
iTRAQ.
Björg Kristjansdottir, Kristina Levan, Karolina Partheen, Elisabet Carlsohn, Karin Sundfeldt
Clinical proteomics - 2013 -
Ovarian cyst fluid is a rich proteome resource for detection of new tumor
biomarkers.
Björg Kristjansdottir, Karolina Partheen, Eric T Fung, Janusz Marcickiewicz, Christine Yip, Mats Brännström, Karin Sundfeldt
Clinical proteomics - 2012 -
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian
mass.
Karolina Partheen, Björg Kristjansdottir, Karin Sundfeldt
Journal of gynecologic oncology - 2011